can tirzepatide cause fainting Compounded Weight Loss Program | GLP-1 Treatment Brightmeds: Compound Tirzepatide Safety Information

Individual experiences vary based on age, hormone levels, underlying health conditions, and the amount of weight lost

Alcohol Consumption and Obesity: An Update

Based on SURMOUNT-1 data, participants on the 15 mg dose were averaging roughly 15% body weight loss by around this point in the trial

These effects are usually short-lived and tend to settle as your body adapts

(New England Journal of Medicine) Why it sits in a different bucket than GLP-1 peptides GLP-1 peptides are generally appetite/satiety signalling first. Tesamorelin is more hormonal axis + fat distribution (VAT) first. (ScienceDirect) For a direct comparison of the leading compounds studied for fat reduction, including GLP-1, dual and triple receptor agonists, see our breakdown of the best peptides for weight loss

Common side effects may include: Mild to moderate nausea Occasional vomiting Constipation or irregular bowel movements Diarrhea General abdominal discomfort or stomach pain Excessive burping and bloating In addition to these, some users have reported more serious or rare adverse reactions, such as: Pancreatitis (inflammation of the pancreas) Gallbladder-related issues, including gallstones Acute kidney injury in sensitive individuals Ozempic face (facial volume loss or sagging) Allergic reactions (rash, itching, or swelling) Changes in mood or behavior, including signs of depression Suicidal thoughts or ideation (seek immediate medical help if experienced) Higher risk of aspiration during procedures involving sedation or anesthesia Increased risk of thyroid tumors, such as medullary thyroid carcinoma (MTC) has been observed in rodent studies